BIOMAT Database Logo BIOMAT Database Logo

Olanzapine for chemotherapy-induced nausea and vomiting control. 2024

Seiji Tsuruta, and Kunihito Matsuguma, and Naruaki Kawasaki, and Ayaka Ishikawa, and Hiroto Ishiki
Department of Dermatologic Oncology, National Cancer Center Hospital, Tsukiji, Chuoku, Tokyo 104-0045, Japan. Electronic address: setsurut@ncc.go.jp.

UI MeSH Term Description Entries
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077152 Olanzapine A benzodiazepine derivative that binds SEROTONIN RECEPTORS; MUSCARINIC RECEPTORS; HISTAMINE H1 RECEPTORS; ADRENERGIC ALPHA-1 RECEPTORS; and DOPAMINE RECEPTORS. It is an antipsychotic agent used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER; and MAJOR DEPRESSIVE DISORDER; it may also reduce nausea and vomiting in patients undergoing chemotherapy. 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine,LY 170053,LY-170052,Olanzapine Pamoate,Zolafren,Zyprexa,LY 170052,LY170052
D000932 Antiemetics Drugs used to prevent NAUSEA or VOMITING. Anti-emetic,Antiemetic,Antiemetic Agent,Antiemetic Drug,Anti-Emetic Effect,Anti-Emetic Effects,Anti-emetics,Antiemetic Agents,Antiemetic Drugs,Antiemetic Effect,Antiemetic Effects,Agent, Antiemetic,Agents, Antiemetic,Anti Emetic Effect,Anti Emetic Effects,Anti emetic,Anti emetics,Drug, Antiemetic,Drugs, Antiemetic,Effect, Anti-Emetic,Effect, Antiemetic,Effects, Anti-Emetic,Effects, Antiemetic
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001569 Benzodiazepines A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring. Benzodiazepine,Benzodiazepine Compounds
D014839 Vomiting The forcible expulsion of the contents of the STOMACH through the MOUTH. Emesis
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Seiji Tsuruta, and Kunihito Matsuguma, and Naruaki Kawasaki, and Ayaka Ishikawa, and Hiroto Ishiki
Olanzapine for chemotherapy-induced nausea and vomiting control.
May 2024, The Lancet. Oncology,
Seiji Tsuruta, and Kunihito Matsuguma, and Naruaki Kawasaki, and Ayaka Ishikawa, and Hiroto Ishiki
Olanzapine for chemotherapy-induced nausea and vomiting control.
May 2024, The Lancet. Oncology,
Seiji Tsuruta, and Kunihito Matsuguma, and Naruaki Kawasaki, and Ayaka Ishikawa, and Hiroto Ishiki
Olanzapine for chemotherapy-induced nausea and vomiting control - Authors' reply.
May 2024, The Lancet. Oncology,
Seiji Tsuruta, and Kunihito Matsuguma, and Naruaki Kawasaki, and Ayaka Ishikawa, and Hiroto Ishiki
Olanzapine for Chemotherapy-Induced Nausea and Vomiting.
October 2016, The New England journal of medicine,
Seiji Tsuruta, and Kunihito Matsuguma, and Naruaki Kawasaki, and Ayaka Ishikawa, and Hiroto Ishiki
Olanzapine for Chemotherapy-Induced Nausea and Vomiting.
October 2016, The New England journal of medicine,
Seiji Tsuruta, and Kunihito Matsuguma, and Naruaki Kawasaki, and Ayaka Ishikawa, and Hiroto Ishiki
Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review.
April 2014, Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer,
Seiji Tsuruta, and Kunihito Matsuguma, and Naruaki Kawasaki, and Ayaka Ishikawa, and Hiroto Ishiki
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting.
July 2016, The New England journal of medicine,
Seiji Tsuruta, and Kunihito Matsuguma, and Naruaki Kawasaki, and Ayaka Ishikawa, and Hiroto Ishiki
Olanzapine: an antiemetic option for chemotherapy-induced nausea and vomiting.
January 2014, Journal of the advanced practitioner in oncology,
Seiji Tsuruta, and Kunihito Matsuguma, and Naruaki Kawasaki, and Ayaka Ishikawa, and Hiroto Ishiki
Olanzapine for chemotherapy-induced nausea and vomiting: systematic review and meta-analysis.
January 2017, Pharmacy practice,
Seiji Tsuruta, and Kunihito Matsuguma, and Naruaki Kawasaki, and Ayaka Ishikawa, and Hiroto Ishiki
Olanzapine for the prevention and treatment of chronic nausea and chemotherapy-induced nausea and vomiting.
January 2014, European journal of pharmacology,
Copied contents to your clipboard!